Univo IRB is your next generation independent review board (IRB) specializing in ethical review of Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research. We offer agile, expert solutions powered by forward-thinking technology and a service-first approach. In all that we do, our tenacious commitment to patient advocacy is our guiding light.
We respect all, harm no one, and protect the welfare of everyone we can. Never satisfied with the bare minimum, we work tirelessly in pursuit of our mission: to be the best at unifying participants with sponsors so that everyone has the access to, right to, and benefit of research.
The Univo Story
2016
Principal IRB, LLC is founded by two individuals determined to bring the principles of human research protection back to the IRB review service industry
2020
Principal IRB receives full AAHRPP accreditation
2023
Principal IRB receives full AAHRPP reaccreditation for 5 years
QHP Capital acquires Principal IRB and invests heavily in experienced IRB leadership and new technology
2024
Principal IRB evolves into Univo IRB, demonstrating our commitment to being your one and only IRB and representing our pledge to protect patients while acting as their voice in research
What’s Next?
Univo IRB is launching the next generation of IRB review services focused on customer service, modern technology, and patient safety
Our Team
Univo IRB consists of a federally regulated IRB committee charged with protecting the rights and welfare of people in research, a business operations team serving clients and supporting the committee, and a leadership team handpicked for their 60+ years of combined commercial and institutional IRB experience. Our leadership team is also supported by senior advisors who represent all aspects of the industry.
Having participated in studies, served as coordinators, and led study teams, we understand what it takes to execute a high-quality, compliant, and safe clinical trial.
Our Partners
